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Abstract: The phytochemical profiling of hemp inflorescences of clonal plants growing in different
conditions related to altitude was investigated. Four strains of industrial hemp (Cannabis sativa
L., family Cannabaceae) of Kompolti variety were selected and cloned to provide genetically
uniform material for analyses of secondary metabolites (terpenes, cannabinoids, and flavonoids) at
two different elevations: mountain (Alagna Valsesia 1200 m ASL) and plains (Vercelli Province
130 m ASL). Environmental conditions influenced by elevation have proven to be important
factors inducing variations in hemp inflorescences’ secondary metabolite composition. In fact,
all plants grown at altitude exhibited a higher total amount of terpenes when compared with plains
counterparts, with β-Myrcene, trans-Caryophyllene and α-Humulene as the main contributors.
A metabolomic, un-targeted approach performed by HPLC-Q-Exactive-Orbitrap®-MS platform
with subsequent data processing performed by Compound Discoverer™ software, was crucial
for the appropriate recognition of many metabolites, clearly distinguishing mountain from plains
specimens. Cannabidiolic acid CBDA was the most abundant phytocannabinoid, with significantly
higher concentrations in the mountain samples. The metabolic pathway of CBGA (considered as the
progenitor/precursor of all cannabinoids) was also activated towards the production of CBCA, which
occurs in considerably 3 times higher quantities than in the clones grown at high altitude. Isoprenoid
flavones (Cannaflavins A, B, and C) were correspondingly upregulated in mountain samples, while
apigenin turned out to be more abundant in plains samples. The possibility to use hemp inflorescences
in pharmaceutical/nutraceutical applications opens new challenges to understand how hemp crops
respond in terms of secondary metabolite production in various environments. In this regard, our
results with the applied analytical strategy may constitute an effective way of phytochemical profiling
hemp inflorescences.
Keywords: hemp; cannabinoids; terpenes; altitude; high-resolution mass spectrometry
1. Introduction
Hemp (cannabis, Cannabis sativa L., family: Cannabaceae) was frequently cultivated in the past,
but its agronomic expansion was interrupted in the beginning of the 1950s for many reasons, one of
them being the presence of psychoactive substance ∆-9-tetrahydrocannabinol (THC) that is produced
by some hemp varieties. Nowadays, this has been partly obliterated and the European Union permits
the cultivation of hemp with THC content of less than 0.20% [1]. For example, in Italy, regulation
n◦242/2017 [2], delineates the conditions for hemp production, its commercialization, and utilization
for specific industrial purposes. Therefore, different genotypes have been registered, along with
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standardized cultivation procedures [3]. Many ecologically, agronomically, and pharmaceutically
positive properties qualify this multifunctional crop as an opportune raw material for various traditional
(fiber, food, oil, medicine) or innovative industrial applications (new biomaterials and biofuels) [4,5].
The European Union has regulated commercial production and distribution of more than 70 hemp
varieties [6], among which the Kompolti variety is one of the oldest. This hemp variety is frequently
cultivated in continental European countries. This well-known dioecious variety was developed
in Hungary as the first hybrid breed [7] in order to produce seeds for oil production, but also its
stalks have been largely exploited. The particularity of this strain is its growing dynamics: it needs a
whopping 6-month flowering period that usually finishes in October. Its macro/microscopical botanical
aspects, geographical distribution, and agricultural status have been comprehensively studied, but
surprisingly, no information is currently available on the content of the high added-value bioactive
substances that are characteristic of its flowers.
The C. sativa inflorescence contains a number of chemically active compounds, such
as cannabinoids, terpenoids, and flavonoids. The most important secondary metabolites are
phytocannabinoids whose acidic forms are exclusively biosynthesized in the glandular trichomes,
which are abundant on the surface of the female flowers [8]. Inflorescences of industrial hemp
varieties, Kompolti included, are particularly rich in cannabidiolic acid (CBDA) that is disposed to the
spontaneous decarboxylation to cannabidiol (CBD) under favorable environmental/conservational
circumstances such as warming and light [9]. CBD is responsible for a variety of pharmacological actions
that may have some remarkable applications, but unlike THC, CBD does not possess any psychoactive
effects [10]. CBD has been studied intensively over the past decade due to its biomedical relevance.
Several studies suggest that CBD can be effective in treating epilepsy and other neuropsychiatric
disorders, including anxiety and schizophrenia [11]. This is the reason why CBD dietary supplements
obtained from different industrial C. sativa chemotypes have become particularly widespread [12].
On the other hand, it is important to evaluate the main factors that determine CBD production in
hemp inflorescence—if it depends on the genetic predisposition of hemp chemovar, or its production
is conditioned by the environment, in particularly the geographical position where plant is bred [13].
Although CBD and THC are the crucial phytocannabinoids, hemp trichomes themselves are
capable of generating a whole series of acidic/decarboxylated phytocannabinoids: about 120 have
been isolated to date [8]. Based on their appearance in the metabolic pathway that involves their
formation, all phytocannabinoids are categorized into 11 subclasses [9], where the central position
belongs to cannabigerolic acid that is synthesized from geranyl diphosphate and olivetolic acid [14].
CBGA further provides tetrahydrocannabinolic acid (THCA), CBDA, and cannabichromenic acid
(CBCA). Cannabigerol (CBG), THC, CBD, and cannabichromene (CBC) are corresponding neutral
equivalents. Other phytocannabinoids detected in hemp inflorescences comprise main oxidation
products of THCA and CBDA: cannabinol (CBN) and cannabinolic acid (CBNA) obtained from
THC(A), and cannabielsoin (CBE) and cannabielsoinic acid that derive from CBDA. The “cannabivarin”
group, commonly following the above-mentioned ones, is produced from condensation of geranyl
diphosphate with divarinic acid, which results in a propyl instead of the pentyl side-chain.
Even though the attention of the scientific community has been focused on major
phytocannabinoids, the phytochemical characterization of C. sativa highlights the presence of various
non-cannabinoids constituents including flavonoids [15]. Their characterization is scarce and random,
especially when the inflorescences of industrial hemp are concerned [13,16,17]. In any case, the
characterization of the cannaflavones—compounds isolated exclusively from hemp—needs further
elucidation, mainly when the inflorescences are concerned.
One non-phytocannabinoid category of bioactive secondary metabolites that is studied in much
more detail is the terpene family. They represent volatile components that has been claimed to have a
synergic action with cannabinoids [18]. Many different monoterpenes and sesquiterpenes are important
components of C. sativa essential oils [19,20], as they define some of the unique organoleptic properties
and may also influence nutraceutical potentials of different hemp strains and varieties [21].
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Selecting a genotype appropriate for a particular end-use application that is adaptable to an
environment is of principal importance for successful hemp cultivation. Hemp is a plant adaptable
to various growing and ecological conditions, but there are no data available in the literature that
concern the differences that may arise from cultivating the same chemovar contemporarily in the plains
and mountain habitats. Different hemp varieties cultivated at high altitudes showed a characteristic
phytochemical and ecological behavior [13].
In this research, our aim was to study whether two very different ecological environments
(mountain and plains) would have a significant impact on phytocannabinoids qualitative and
quantitative content, flavonoids presence, and terpenoids profile, in order to study the plant
phytochemical behavior and its potential to provide nutraceutical substances.
Four strains of industrial hemp (Kompolti) were selected and cloned to provide genetically
uniform material for analyses of secondary metabolites (cannabinoids, terpenes, and flavonoids) of
clones of the same plant grown at different elevation in two sites representative of lowland (Vercelli
Province 130 m ASL) and mountain (Alagna Valsesia 1200 m ASL) during the growing season 2018.
2. Results and Discussion
Multi-targeted applications of industrial hemp with the environmental benefits related to its
cultivation, have raised interest in its production. Special attention has been paid to C. sativa
inflorescences that represent a promising added-value product with remarkable pharmacological and
nutraceutical effects [13,16,22,23]. The phytochemical composition of inflorescences has been studied
intensively, but there is not substantial information that regards the differences that may rise due
to geographical/microclimate factors. In this experiment, raw inflorescences material obtained from
plants cultivated in the Italian Alps at two different elevations was evaluated. Mountain (M) region
was located in the commonality of Alagna Valsesia (1200 m ASL), whereas plains (P) cultivation was
performed in the Province of Vercelli (130 m ASL).
2.1. Terpenoids Profile Estimated by HS-SPME- GC-MS Analytical Procedure
Monoterpenes, diterpenes, triterpenes, and sesquiterpenes are important components of the
C. sativa resin responsible for its unique aromatic properties [20,21]. Considering the terpenoids fraction
characterized by high-volatile features, the headspace solid-phase microextraction-gas chromatographic
mass-spectrometric (HS-SPME-GC-MS) analytical approach presents the best methodology for their
comprehensive profiling, as was confirmed by our recently published studies [12,24,25]. SPME is a
simple and fast modern tool used to characterize the volatile fraction of secondary metabolites of
different parts of plants [26,27] and animals [28].
Complete data concerning the terpenes fingerprint in the two groups of Kompolti inflorescences
are summarized and reported in Table 1 It was possible to define 20 compounds that belong to the
mono/di/tri terpenes and 21 sesquiterpenes. Our results are qualitatively comparable with those
reported by others [19,20,22,29]. The most remarkable aspect is that four M clones expressed significantly
higher amounts of both terpenoids subgroups, with high variation in the individual quantitative
profile. This is the reason why the results are elaborated by statistical approach that consisted of the
comparation of relative amounts of each compound between mountain and corresponding plain clone.
Generally, the predominant monoterpene was β-myrcene, followed by both α-/β-pinene and limonene,
although without uniformity between four plants (Table 1). For example, the plant M2 was particularly
rich in β-myrcene, followed by β-pinene and limonene, but not α-pinene. On the other hand, the plant
1 (both M and P samples) expressed its specificity in the accumulation of β-ocimene, while others were
very poor in its presence. Also, plant 1 contained the oxygenated terpene 4,8-epoxy-p-menth-1-ene
that was completely absent from other inflorescences.
Geographic origin, accompanied by environmental conditions, turned out to be an important
variable that determined the sesquiterpenes’ quantitative characteristics: mountain plants exhibited
higher total amounts than plains counterparts, with trans-caryophyllene and α-humulene as the main
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contributors (Table 1). Those two compounds are typical constituents of C. sativa essential oil [30], and
also here showed a quite stable relevance. Selina-3,7(11)-diene was detected in a moderate amount in all
mountain samples, but its presence was not detected in two plains clones. α-ylangene, α-bergamotene
and β-farnesene expressed highly inconsistent trends. For example, P1 samples were particularly
abundant in β-farnesene, while in plant 3 (both P and M samples) it was absent. All samples contained
longicyclene, the sesquiterpene rarely identified in C. sativa inflorescences, with the exception of one
drug-type chemovar [31].
In all cases, the qualitative and quantitative differences observed in the chemical profile of terpene
fractions were conditioned by many factors such as, hemp variety, cultivation and environmental
conditions, harvest time and post-harvest conditions, storage and drying of raw plant, and extraction
procedure applied. Despite the fact that within each group, plants were grown under identical
conditions and treated in the same way, it remains an open question why each of them had its specific
terpenoids fingerprint.
Molecules 2020, 25, 1381 5 of 16
Table 1. Mono/di/triterpenes and sesquiterpenes extracted and identified by headspace solid-phase microextraction-gas chromatographic mass-spectrometry
(HS-SPME-GC/MS) in mountain (M) and plains (P) inflorescences.
MONO/DI/TRI Terpenes M1 P1 p
Value b
M2 P2 p
Value
M3 P3 p
Value
M4 P4 p
Valuemean a ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD
α-Pinene 3823.9 81.1 2705.8 152.3 0.014 2401.3 56.3 4659.2 394.3 0.013 4870.9 3.7 1944.8 65.0 <0.001 1788.6 190.1 1560.3 89.1 n.s.
α-Fenchene n.d. n.d. 26.3 3.0 <0.001 44.4 27.6 n.d. n.d. <0.001 n.d. n.d. 13.1 1.1 <0.001 n.d. n.d. 12.4 2.6 <0.001
Camphene 202.6 4.7 139.1 5.2 0.008 991.6 6.8 270.2 10.3 <0.001 292.5 5.3 91.0 1.1 <0.001 162.0 20.1 121.6 0.2 0.004
β-Pinene 2074.0 152.8 2067.3 149.8 0.050 12965.6 55.6 2979.8 233.7 <0.001 2258.6 20.7 1058.5 94.8 0.0015 1456.0 336.7 1230.8 3.0 n.s.
β-Myrcene 26,294.5 450.3 23,745.1 1070.4 0.020 76,993.1 4716.5 16,893.5 519.5 0.0008 23,597.9 716.7 5949.9 24.1 0.0002 26,723.6 2988.9 11,660.5 1778.3 0.004
Limonene 2603.1 112.5 3023.2 150.3 n.s. 11472.7 276.0 4184.1 134.1 <0.001 5565.0 846.0 962.2 1.4 0.011 5538.9 93.8 3883.5 8.0 <0.001
β-Phellandrene 642.8 6.2 628.5 40.6 n.s. 2017.8 10.1 515.9 34.6 0.0012 662.0 348.3 188.5 2.2 0.0015 681.6 54.9 417.5 20.4 0.026
Cis-ocimene 352.70 1.6 321.5 60.3 n.s. 132.0 2.2 38.8 4.5 <0.001 44.6 1.0 8.6 0.7 <0.001 34.4 9.8 34.5 3.2 n.s.
γ-Terpinene 37.0 5.9 23.3 7.6 0.002 86.5 1.0 77.6 0.4 0.004 69.0 10.9 49.9 1.4 0.054 18.5 5.3 15.6 0.8 n.s.
β-Ocimene 6571.3 25.5 5555.3 40.1 0.001 135.20 5.1 138.0 2.0 n.s. 493.7 16.3 28.9 28.9 <0.001 139.6 6.7 110.4 6.3 0.001
α-Terpinolene 136.4 15.4 143.1 26.3 n.s. 486.1 48.4 190.2 41.2 0.0002 274.3 7.7 45.4 0.9 <0.001 192.0 6.5 144.6 10.3 0.002
Terpene 6.0 0.1 4.8 0.1 0.007 12.8 0.9 5.3 0.7 <0.001 4.5 0.2 1.2 0.1 <0.001 11.4 0.4 0.8 0.0 <0.001
α-Fenchone 47.5 2.6 20.0 7.0 0.009 84.2 28.2 74.6 24.6 0.045 74.3 14.3 9.4 0.6 0.017 41.1 0.5 36.6 1.6 0.020
Alloocimene 80.9 0.1 91.7 17.1 n.s. 37.6 4.1 24.2 1.2 0.015 12.1 4.1 2.2 1.2 <0.001 23.3 8.3 17.2 6.2 0.036
Linalyl oxide 19.6 0.7 16.2 2.1 0.070 8.5 0.1 7.2 5.3 0.040 18.7 1.2 17.4 1.7 n.s. 21.1 0.8 16.6 1.6 n.s.
4,8-Epoxy-p-menth-1-ene 147.8 16.8 167.9 13.0 0.012 n.d. n.d. n.d. n.d. - n.d. n.d. n.d. n.d. - n.d. n.d. n.d. n.d. -
Pinalol 117.0 1.6 130.0 20.0 n.s. 271.2 2.1 269.6 11.7 n.s. 248.2 31.2 229.8 20.2 0.1 139.8 12.4 131.2 5.9 0.1
β-Linalool 149.6 7.7 163.0 49.5 n.s. 693.6 3.4 576.4 31.3 0.028 617.0 49.8 54.9 2.4 <0.001 1118.5 94.2 880.7 8.6 0.010
α-Fenchol 68.0 43.0 29.0 10.0 n.s. 164.6 48.2 130.8 35.9 n.s. 368.7 36.6 12.2 2.3 0.0014 171.9 71.6 12.7 2.7 0.060
Verbenol 89.8 36.4 37.7 18.9 0.035 204.5 155.1 65.1 0.6 n.s. 212.1 159.9 2.4 0.5 n.s. 6.8 6.5 11.7 1.3 n.s.
tot 43,464.5 39,038.8 109,203.3 31,100.5 40,141.9 11,038.4 38269.1 20,299.2
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Table 1. Cont.
Sesquiterpenes M1 P1 p
Value b
M2 P2 p
Value
M3 P3 p
Value
M4 P4 p
Valuemean a ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD mean ± SD
α-Ylangene 130.8 7.3 201 19 0.044 47.1 13.7 60.7 6.6 0.05 15.6 6.5 3.4 0.9 0.007 13.3 6.5 9.2 0.2 n.s.
α-Copaene 41.7 1.2 50.7 4 n.s. 21.9 0.1 48.8 14.6 n.s. 9.7 0.6 1.9 0.2 0.002 22.1 2.3 20.8 0.8 0.027
Zingiberene 62.6 6.4 106.8 10.5 0.02 68.3 6.8 41.7 11.2 <0.001 26 0.6 35 12.3 0.081 122.7 11.7 111.8 4.9 n.s.
Longicyclene 314.2 80.9 417.5 59.9 0.09 44.2 0.7 25 17.2 n.s. 43 0.9 2.5 0.8 <0.001 302.6 63.2 207.1 11.2 0.08
α-Bergamotene 976.9 58.1 1440.9 115.3 n.s. 831.8 310.9 381.8 49.2 n.s. 326.5 54.1 77.9 13.9 0.004 3140.1 204.7 2395.8 86.2 0.008
Trans-Caryophyllene 6487.1 113.7 3668.7 502 0.008 9206.9 144.9 3797.7 41.8 0.007 3345.5 456.2 829.2 28.2 <0.001 7017.4 922.6 1684.6 38.2 <0.001
Aristolene 55.8 3.6 105 9.8 0.005 18.4 0.7 28 10.3 n.s. 2.63 2.63 0.1 0.91 n.s. n.d. 819 114.4 0 <0.001
Isoledene 33.2 6.9 67.3 10.9 0.004 31.9 11.9 31.8 10 n.s. 8.4 4.8 2.69 1.8 n.s. 13.4 1.1 12.7 0.4 n.s.
β-Santalene 12.3 2.2 23.9 3.7 0.005 6.9 0.2 7 2.5 n.s. 4.1 3.15 0.38 0.21 n.s. 8.2 1.3 10.7 2.5 n.s.
Aromadendrene 152 40.2 76.3 9.3 n.s. 195.7 1.4 7.6 0.1 <0.001 19.9 1.4 14.3 2.8 n.s. 22.4 1.4 2.8 0.3 0.001
α-Humulene 3190 15 2099 183.2 0.007 3107.1 177.4 1284.2 9.9 0.002 3206.1 204.5 306.2 15.8 0.014 3431.4 87.2 2660.4 100.2 <0.001
β-Farnesene 51.9 41.3 1495.4 4.6 <0.001 1105.7 14.3 249.6 59.6 0.002 n.d. n.d. n.d. n.d. - 1494.2 17.4 1244.8 13.4 0.006
β-Selinene 416.4 29.7 632.4 49.2 0.003 245.5 47.2 502.8 50.4 <0.001 123.2 1.9 211.7 10.6 0.003 112.6 28.5 271.5 7.6 0.004
α-Selinene 260.8 11.9 379.9 46.2 0.027 61.8 6.4 145.4 35.1 0.034 4.9 0.4 23.3 6.1 0.033 74.5 4.2 71.2 8.7 n.s.
β-Bisabolene 739.6 30.4 293.7 156.9 0.05 1515.6 29.5 581.2 21.5 <0.001 557 51.2 129.9 8.8 0.003 1278.2 8.9 1024.2 14.3 0.003
α-Farnesene 213.8 29.6 357.2 68.4 0.045 661.2 21.3 314.2 14.4 0.008 160.8 26.6 37.9 21.2 0.031 500.2 18.2 583.2 86.2 n.s.
δ-Cadinene 128.2 20.8 215.1 38.5 n.s. 63.5 4.2 74.2 4.6 0.013 124.4 0.2 23.9 3.7 0.008 66.8 5.2 33.4 20.2 n.s.
β-Maaliene 657.2 25.9 1048 224.2 0.008 297.8 12.4 197.2 10.2 0.0078 63.3 10.5 59.6 14.1 n.s. 354.2 25.1 362 2.7 n.s.
Selina-3,7(11)-diene 1821 134.4 n.d. n.d. <0.001 1623.3 157.2 n.d. n.d. <0.001 581.6 81.6 132.5 12.6 0.007 1196.2 25.2 992.3 102 n.s.
Caryophyllene oxide 59.2 6.3 63.2 32 n.s. 68.2 6.9 30.1 4.3 0.024 18.9 4.1 6 0.7 0.006 67.2 2.4 73.6 4.6 n.s.
Guaiol 114.5 20.9 144.8 48.2 n.s. 326.2 28.1 280.4 70.7 n.s. 214.4 56.6 337 20.2 n.s. 289.2 15.4 227.9 8.6 n.s.
10-Epi-γ-Eudesmol 329.6 26.7 170.7 47.2 0.003 425.2 42.4 331.2 3.1 0.004 243.2 51.4 42.5 0.1 0.005 181.1 21 295.2 3.1 n.s.
tot 16,248.8 13,057.5 19,974.2 8420.6 9099.2 2277.9 19708.0 12,409.6
a Data are given as mean ± SD (standard deviation), n = 3 (expressed as µg/g SI equivalents). b p-value—t-test with 95% two-tailed confidence interval for difference of means.
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2.2. Quantification of Cannabinoids by HPLC-Q-Exactive-Orbitrap®-MS Analysis
Based on the available commercial cannabinoids standards, quantification of inflorescence extracts
was performed by applying our validated method [13,24,25], as explained in detail in the material
and methods section. Quantitative data related to the analysis of the content of phytocannabinoids in
the two inflorescences groups performed by means of the HPLC high-resolution mass spectrometry
(HRMS, Q-Exactive-Orbitrap®-MS) are shown in Table 2. The quantification was performed for CBD
(cannabidiol), ∆9-THC (delta-9- tetrahydrocannabinol), CBN (cannabinol), CBC (cannabichromene),
CBG (cannabigerol), CBDV (cannabidivarin), ∆9-THCV (delta-9-tetrahydrocannabivarin) and the acid
forms CBDA (cannabidiolic acid),∆9-THCA (delta-9- tetrahydrocannabinolic acid), CBNA (cannabinolic
acid), CBCA (cannabichromenic acid), CBGA (cannabigerolic acid), CBDVA (cannabidivarin acid)
and ∆9-THCVA (delta-9-tetrahydrocannabivarin acid). In contrast to what was found for volatile
terpenoids, the results obtained for cannabinoids were more uniform with respect to the cultivation site.
It was therefore feasible to perform paired statistical evaluations combining the specimens from both
locations. Since the Kompolti chemovar belongs to the fiber-type hemp, it is not surprising that CBDA
was the most abundant phytocannabinoid with significantly higher concentration in the mountain
than in the plains. Those values (both for M and P group) are higher than those recently reported
by [32,33]. The THC and THCA content were below legal limits, but the occurrence of traces of CBNA
—THCA’s non-enzymatic, oxidative product—should be taken into consideration when so-called “total
THC” amount is concerned. Furthermore, it is noted that the metabolic pathway of CBGA (considered
as the progenitor/precursor of all cannabinoids) was activated towards the production of CBCA, which
occurred in considerably 3 times higher quantities in the samples cultivated at high altitude.
The presence of similar quantities of CBD in the mountain and plains specimens indicated that
geographical location did not significantly influence decarboxylation of CBDA. This process naturally
occurs under the action of heat and light, but here it is more probable that it was caused by Kompolti’s
predisposition to have prolonged flowering in the late summer/beginning autumn season, when
the average daily temperatures are moderately higher in both locations. Therefore, a genetically
predisposed flowering season may have led to a partial conversion of the parent CBDA into its neutral
counterpart, as was demonstrated for Futura and Finola 75 varieties [13].
Table 2. Results regarding the bioaccumulation of the main cannabinoids in the inflorescences of mountain
Kompolti samples and corresponding plains clones (µg/g, mean of four biological samples ± SD).
Mountain Plains Statistical
SignificanceMean SD (±) Mean SD (±)
Neutral forms
CBD 5300 3500 6000 3800 ns
∆9-THC <LOQ / <LOQ / /
CBN <LOQ / <LOQ / /
CBC 460 120 120 50 0.005
CBG 110 10 180 80 <0.001
CBDV 250 400 450 40 <0.001
∆9-THCV <LOQ / <LOQ / /
Acid forms
CBDA 99,600 24,800 68,220 15,000 0.01
∆9-THCA 840 200 1010 400 ns
CBNA 40 4 50 10 ns
CBCA 1570 200 570 30 0.008
CBGA 7410 900 4510 400 0.015
CBDVA 310 70 240 20 ns
∆9- THCVA <LOQ / <LOQ / /
LOQ–limit of quantification 1 µg/g for all phytocannabinoids. ns: not significative
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2.3. HPLC-Q-Exactive-Orbitrap®-MS Untargeted Metabolomics Approach: Phytocannabinoids Profiling and
Identification of Polyphenolic Structures
Metabolomic fingerprinting of the inflorescences that can be used for pharmacological/
nutraceutical purposes is important to evaluate a plant metabolite quality and variability.
Chromatographic/HRMS fingerprints have been used in the modelling and prediction of
pharmacological activities of many medicinal plants [34], but only sporadically for cannabis. Also in
this study, as performed in our recently published work [13] the compounds that characterize hemp
inflorescences were identified by HPLC-Q-Exactive-Orbitrap®-MS untargeted metabolomics approach
that consist of chromatographic separation, HRMS acquisition, and post-analysis data elaboration
applying the Compound Discoverer software. Unlike in the above-mentioned paper, here we analyzed
the samples separately, using two types of ionization: both positive and negative (Table 3) that enabled
a more profound approach. The negative mode revealed the presence of about 80 compounds, whereas
the positive mode individuated more than 190. By introducing the detection in negative polarity,
it was possible to identify compounds not detected previously [13]. For example, CBGA methyl
ester (CBGMA) was not detected in positive ionization, but its presence was clearly confirmed by
fragmentation pattern obtained in negative mode (Figure 1). This strategy consequently allowed for
an in-depth cluster analysis that clearly demonstrated the differences between the samples coming
from the mountains and those cultivated in the plains (Figure 2). Two acquisition modes showed to be
complementary in the statistical evaluation of differences between two samples group. As regards the
data obtained, it was possible to detect other minor secondary metabolites already identified in other
cannabis species. The CBD-family remains to be most abundant (Table 3), enriched by the presence
of two sesquiterpene CBDA esters. This CBDA-terpene (inter)reaction needs further elucidation,
especially whether it depends on climate/environmental conditions [8,9,13].
In any case, special attention must be paid to cannaflavins that belong to the class of
prenylflavonoids. This flavins are secondary metabolites exclusive to the Cannabis genus and were
detected in both environments. Their notable presence in mountain samples points towards alternations
in their synthesis [16]. The higher levels detected in the mountain samples may possibly be a consequence
of the lower average temperature, combined with high solar radiation experienced at the beginning
of plant flowering. In fact, it was reported that different classes of flavonoids are involved in plant
protection mechanisms, specifically for their radical scavenger activity and screening ability against
short wavelength UV-B light [35].
Furthermore, in the Kompolti inflorescence, the remarkable presence of a signal with m/z value at
433.14931 was identified and leads towards the recognition of a particular flavonoid: 3-methoxinobiletin
(3,3′,4′,5,6,7,8-heptamethoxyflavone) (Figure 3). This compound has not been reported for any variety
of hemp so far. Furthermore, it belongs to the class of polymethoxyflavones that have anti-inflammatory
and anti-carcinogenic activities and occur as “novel nutraceutical compounds” [36]. In order to perform
its absolute identification, it is necessary to isolate it from the inflorescence and define it with a more
detailed analytical approach, also including NMR analysis.
Our metabolomics mapping identified two important phytohormones: salicylic and abscisic acid
that have not been reported for cannabinoids inflorescences so far. Their presence was confirmed in
our mountain samples, but their amount turned to be more than 10 times higher in lowland specimens.
These findings are important to highlight because of the fact that salicylic acid was identified as
‘calorigen’, the plant hormone that induces heat-production in some inflorescences [37]. Also, salicylic
acid plays a critical role in the defense against biotrophic pathogens and in the response of plants to
abiotic stress, predominantly drought, temperature, heavy metals and, osmotic stress [38]. As far as
abscisic acid is concerned, it is well known that stress conditions affect its endogenous production and
catabolism rates, while exogenously applied abscisic acid influenced the content and biosynthesis of
terpenoids in C. sativa [39].
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Table 3. Results regarding metabolomic identification in Kompolti inflorescences.
Class Compound Formula (M + H)+/Main Fragment (M −H)−/Main Fragment RegulationMountain vs.
PainsPhytocannabinoids
CBG cannabigerol class
CBG C21H32O2 317.2475/193.1223 315.2329/191.1078
Upregulated in mountain
Sesqui-CBG C26H40O2 385.3173/193.1223 n.i.
6,7-epoxy-CBG C21H32O3 333.2424/315.1867 n.i.
CBGVA C20H27O4 333.2060/173.0962 331.1915/313.1809
6,7-epoxy-CBGA C22H32O5 377.2323/341.2113 375.2185/257.3077
CBGA C22H31O4 361.2375/219.1017 359.2228/191.1078
CBGMA C23H34O4 n.i. 373.2384/355.2293
Sesqui-CBGA C27H40O4 n.i. 427.2854/409.2748
CBD (cannabidiol) class
CBDV C19H26O2 287.2006/165.0914 285.1860/217.1234
Upregulated in mountain
Nor-CBD C20H28O2 301.2162/179.1070 299.2017/231.1391
CBD C21H30O2 315.2319/193.1223 313.2173/191.1078
CBDM C22H32O2 329.2475/229.0812 327.2329/205.1234
CBDVA C20H26O4 331.1904/313.1801 329.1758/217.1123
Nor-CBDA C20H28O4 345.2060/327.1956 343.1915/231.1391
CBDA C22H30O4 359.2219/341.2114 357.2017/245.1547
CBDMA C32H46O4 n.i. 371.2228/259.1704
Sesquiterpene-CBDA ester C32H46O4 495.3469/341.2114 493.3323/357.2017
γ-Eudesmyl-CBDA ester C37H54O4 562.4017/341.2114 561.3949/357.2017
∆9-THC tetrahydrocannabinol class
THCV C19H26O2 287.2006/165.0914 285.1860/217.1234
nsTHC C21H30O2 315.2319/193.1223 313.2173/n.i.
THCVA C20H26O4 331.1904/313.1801 329.1758/189.0921
THCA C22H30O4 359.2219/341.2114 357.2071/245.1547
CBC cannabichromene class
CBCV C19H26O2 287.2006/165.0914 285.1860/163.0765
Upregulated in mountainCBC C21H30O2 315.2319/193.1223 313.2173/n.d.
CBCVA C20H26O4 331.1904/313.1801 329.1758/189.0921
CBCA C22H30O4 359.2219/341.2114 357.2071/313.2179
CBN cannabinol class
CBN C21H26O2 311.2007/223.1118 309.1860/n.i. ns
CBNA C22H26O4 355.1904 337.1800
Cannaflavin A C26H28O6 437.1964/313.0709 435.1813/309.0413
Isoprenoid flavones Cannaflavin B C21H20O6 369.1333/313.0706 367.1195/309.0499 Upregulated in mountain
Cannaflavin C C26H28O6 437.1964/313.0709 435.1813/309.0414
Polymethoxyflavones 3-Methoxynobiletin C22H24O9 433.14980/403.10296 n.i. Upregulated in mountain
Flavones apigenin C15H10O5 271.0601/nd 269.0455/117.0348 Upregulated in plains
Phenolic acid
Salicylic acid C7H6O3 n.i. 137.0426/95.8554 Upregulated in plains
Abscisic acid C15H20O4 n.i. 263.1289/219.1391
(M + H)+: exact mass of pseudomolecular ion acquired in full scan positive ionization mod; (M − H)−: exact mass of pseudomolecular ion acquired in full scan negative ionization mode;
main fragment: the base fragment in MS/MS spectrum; ns: not significant differences between two chemovars; A: acid; V: C3 chain length; Nor: C4 side chain length; M: methyl ester; n.i.:
not identified; Regulation: hierarchical cluster analysis (Figure 3).
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3. Materials and Methods
3.1. Experimental Fields and Samples Collection
3.1.1. Clones
Seedlings of C. sativa were grown starting from commercial certified seeds of the Kompolti variety.
In a 120-plant seedling tray, the most vital plants were chosen for cloning to provide material of genetic
homogeneity. Four pairs of clone plants were chosen to grow at altitude versus in the plains, assigning
them a number indicating a single plant strain (1,2,3,4) and a letter for the growing site (M for ones
destined to be grown at altitude and P for ones destined to be grown in the plains). These strains
included only low ∆ 9-THC fiber strains. Plants were grown potted in a loam-vermiculite-sand mixture
(6:2:1) under ambient greenhouse conditions. Cuttings were taken from the parent pistillate plant of each
strain, treated with Rootone, and rooted in perlite. The standard soil permitted to avoid pedotrophic
variability. Then, the three-week rooted plants potted in the same substrate were transported in the
mountain location (municipality: Alagna Valsesia; elevation 1200 m ASL; latitude 45◦51′ N; longitude
7◦56′ E) and a lowland location (municipality: Vercelli 130 m ASL; latitude 45◦19′ N; longitude 8◦22′ E).
The geographical area is located in Piedmonte, north of Italy, in the Western Alps ecoregional section
for what concerns the mountain location, with prevailing temperate semi-continental bioclimates and
in the Po Plain ecoregional section, with prevailing temperate subcontinental bioclimate for what
concerns the lowland experimental station [40].
3.1.2. Plant Parts Sampled
Harvest of inflorescences was carried out at flowering, corresponding to the phenological codes
2202 [41]. It was considered “inflorescence” only the 15 cm upper part of the stem. The sectioned parts
of the inflorescences were left to air-dry, protected from light in open containers at room temperature
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(25 ◦C) for 2 weeks [42]. They were subsequently preserved in plastic bags under vacuum stored in a
cool room until analysis. The low temperature avoided changes in metabolites, cannabinoids, and
terpenes. The inflorescences material of each clone was sampled five times to realize the analyses.
Then, the extracts were injected three times in the analytical instruments.
3.2. Chemical and Reagents
For head-space (HS) analysis, the SPME coating fiber (DVB/CAR/PDMS, 50/30 µm) was obtained
from Supelco (Bellefonte, PA, USA) while acetonitrile, 2-propanol, formic acid (all LC-MS grade)
were purchased from Carlo Erba (Milan, Italy). Ultrapure water was obtained through a Milli-Q
system (Millipore, Merck KGaA, Darmstadt, Germany). All cannabinoids were analytical standards at
concentration 1mg/mL (methanolic solution) were purchased from Sigma Aldrich, Round Rock, Texas).
3.3. Superfine Grinding (SFG) Sample Preparation
Samples (1.0 g each) were transformed in fine powder in a high intensity planetary mill at a
frequency of 25 Hz for 1 min, using two 50 mL jars (precooled with liquid nitrogen) with 20 mm
stainless steel balls.
3.4. Accelerated Solvent Extraction (ASE) for Cannabinoids Profiling
The extraction procedure was done according to the our already-published procedure [12,24,25].
In brief, all extractions were performed by accelerated solvent extraction apparatus using an ASE 350
(Thermo-Fisher Scientific, Waltham, MA, USA) with 34-mL stain steel cells. Inflorescence powder
(100 mg) was mixed with an equal weight of diatomaceous earth and transferred into the cell.
One-hundred µL of solution containing the IS (diazepam 1 mg/mL) was added and cell was filled
with diatomaceous earth. ASE operation parameters were as following: room temperature of 25 ◦C,
pressure (1500 psi), number of static cycles (2 cycles, 5 min each), purging time (60 s with nitrogen) and
rinse volume (90%). Extracts (25 mL) obtained using pure methanol and were dried under vacuum;
the residue was dissolved in 1 mL of acetonitrile. The resultant solution was diluted (1:10) in starting
mobile phase, 2 µL were submitted to analysis by HPLC-Q-Exactive-Orbitrap-MS. Commercially
available officinal plants mixture previously analyzed for the absences of cannabinoids served as blank
samples and were used to obtain the matrix-matched calibration curves. Matrix-matched calibration
curves were obtained by spiking the standard solutions of 14 commercially available cannabinoids that
covered the two-concentration range: 0.1 to 10 µg/g and 10–1000 µg g−1.
3.5. Cannabinoids HPLC-Q-Exactive-Orbitrap-MS Evaluation
The cannabinoids profile was assessed employing the method recently published by us [13,24].
HPLC-Q-Exactive-Orbitrap®-MS analysis was achieved on an HPLC Surveyor MS quaternary pump,
a Surveyor AS autosampler with a column oven, and a Rheodyne valve with a 20-µL loop system
(Thermo Fisher Scientific, San Jose, CA, USA) using a reverse-phase HPLC column 150 × 2 mm i.d.,
4 µm, Synergi Hydro RP, with a 4 × 3 mm i.d. C18 guard column (Phenomenex, Torrance, CA, USA).
The mobile phase consisted of water and acetonitrile gradient both acidified with 0.1% formic acid.
The gradient (flow 0.3 mL/min) started with 95% of 0.1% aqueous formic acid with a linear decrease
up to 5% in 30 min. The mobile phase was returned to initial conditions at 35 min, followed by a
5-min re-equilibration period. The column and sample temperatures were 30 ◦C and 5 ◦C, respectively.
The mass spectrometer Thermo Q-Exactive Plus (Thermo Scientific, San Jose, CA, USA) was equipped
with a heated electrospray ionization (HESI) source. Capillary temperature and vaporizer temperature
were set at 330 and 380 ◦C, respectively, while the electrospray voltage was set at 3.30 kV. Sheath and
auxiliary gas were 35 and 15 arbitrary units, with S lens RF level of 60. The mass spectrometer was
controlled by Xcalibur 3.0 software (Thermo Fisher Scientific, San Jose, CA, USA. Qual Browser in
Xcalibur 3.0 software) was used for the exact mass and isotopic pattern determination. The FS-dd-MS2
(full scan data-dependent acquisition) in positive and negative mode was used for both screening
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and quantification purposes. Resolving power of FS adjusted on 70,000 FWHM at m/z 200, with
scan range of m/z 100–900. Automatic gain control (AGC) was set at 3e6, with an injection time of
200 ms. A targeted MS/MS (dd-MS2) analysis operated in both positive and negative mode at 35,000
FWHM (m/z 200). The AGC target was programmed at 2e5, and maximum injection time was set at
100 ms. Fragmentation of precursors was optimized as three-stepped normalized collision energy
(NCE) (20, 40 and 40 eV). Detection was based on retention time and on calculated exact mass of the
protonated/deprotonated molecular ions, accompanied with fragmentation pattern [13].
3.6. HPLC-Q-Exactive-Orbitrap-MS Untargeted Metabolomics Approach
Raw data from high resolution mass spectrometry were elaborated with Compound Discoverer™
(Thermo Scientific), that facilitated the peak recognition, retention times arrangement, profile
assignment, and isotope pattern [43]. Metabolite identification was based on accurate mass and mass
fragmentation pattern spectra against MS-MS spectra of compounds available on mzCloud database
(HighChem LLC, Slovakia, https://www.mzcloud.org) and in the literature [44]. The ChemSpider Web
services (https://www.chemspider.com) and Human Metabolome platform (https://hmdb.ca/) was used
as supplementary confirmation tools. If mass fragmentation pattern did not correspond to any of
databases annotated by Compound Discoverer™ software, manual confirmation of their fragments
using program ChemDrow was completed.
3.7. HS-SPME and GC-MS Analysis for Terpenes Examination
Complete analytical technique was provided in detail in our recently published article [12,24,25].
In brief, 100 mg of inflorescence powder was put into 20 mL glass vials along with 100 µL of the IS
(4-metil-2-pentanone, 20 mg/mL in 2-propanol). A cap with a silicon/PTFE septum (Supelco, Bellefonte,
PA, USA) was used to close the vial, which was then kept in the temperature block (37 ◦C), (CTC
Analytics, Zwingen, Switzerland). At the end of the sample equilibration time (30 min), a conditioned
(60 min at 280 ◦C) SPME fiber was subjected to the sample for 120 min using a CombiPAL system
injector autosampler (CTC Analytics, Zwingen, Switzerland).
Analyses were performed with a Trace GC Ultra coupled to a Trace DSQII quadrupole mass
spectrometer (MS) (Thermo-Fisher Scientific, Waltham, MA, USA) equipped with an Rtx-Wax column
(30 m × 0.25 mm i.d. × 0.25 µm film thickness) (Restek, Bellefonte, PA, USA). The oven temperature
program was: from 35 ◦C, held for 8 min, to 60 ◦C at 4 ◦C/min, then from 60 to 160 ◦C at 6 ◦C/min and
finally from 160 to 200 at 20 ◦C/min. Helium was the carrier gas, at a flow rate of 1 mL/min. The MS
was operated in electron impact (EI) ionization mode at 70 eV, m/z range of 35–350. An alkanes mixture
(C8-C22, Sigma R 8769, Saint Louis, MO, USA) was run under the same chromatographic conditions
as the samples to calculate the Kovats Retention Indices (RI) of the detected compounds [27,45].
Compounds were recognized by comparing with authentic standards or by using the Kovats retention
indices in combination with the literature and via the National Institute of Standards and Technology
(NIST) MS spectral database. The semi-quantitative evaluation was achieved using the internal standard
procedure and the results were expressed as µg/g IS equivalents.
3.8. Statistical Analysis
The relative intensity of chromatographic peaks was processed by Compound Discoverer platform
that enabled Hierarchical Cluster Analysis. Differences between two groups were evaluated using a
two-tailed Student’s t-test from the BioVinci statistical program (Version 1.1.4., BioTuring, Inc. 2018
California, CA, USA). A p-value of less than 0.05 was deemed statistically significant.
4. Conclusions
The quantity and quality of secondary plant metabolites are often attributed to a combination
of genetic and environmental factors. Eliminating genetic and pedotrophic factors, the results
accomplished in this study indicate qualitatively and quantitatively intraspecific variations in
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secondary metabolites, other than a major effect attributable to the ecological conditions related
to the elevation of the location. A mountain environment, with condition of UV length exposure
and critical conditions, deeply influences the quantity of the inflorescence compounds, favoring the
production of CBDA and cannaflavins. Information regarding the differences in industrial hemp
inflorescences phytochemical profile supports hemp cultivation in mountain areas as a source of
pharmacologically active cannabinoids, terpenes and cannaflavones that are considered also as
promising nutraceuticals. Metabolomics approaches delineated this crop as resourceful and highly
adaptable to the variation of climate/geographical conditions.
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